Cargando…
260 Responses following COVID-19 vaccination in patients with autoimmune skin disease
Autores principales: | Sprow, G., Afarideh, M., Dan, J., Keyes, E., Grinnell, M., Concha, J., Vazquez, T., Diaz, D., Kodali, N., Werth, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296915/ http://dx.doi.org/10.1016/j.jid.2022.05.267 |
Ejemplares similares
-
Autoimmune Skin Disease Exacerbations Following COVID-19 Vaccination
por: Sprow, Grant, et al.
Publicado: (2022) -
Sclerotic skin disease development following COVID-19 vaccination
por: Sprow, Grant, et al.
Publicado: (2022) -
278 Photo validation study using cutaneous dermatomyositis disease area and severity index in dermatomyositis patients
por: Grinnell, M., et al.
Publicado: (2022) -
Bullous systemic lupus erythematosus in females
por: Sprow, Grant, et al.
Publicado: (2022) -
ODP260 New Type of Autoimmune Diabetes
por: Kumar, Surina, et al.
Publicado: (2022)